The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Italian Population-Based Values of EQ-5D Health States
Open accessAbstract
Objective To estimate a value set for the calculation of Italian-specific quality-adjusted life years (QALYs), based on preferences elicited on EuroQol five-dimensional (EQ-5D) questionnaire health states using the time trade-off technique.Methods The revised standard Measurement and Valuation of Health protocol was followed. Twenty-five health states, divided into three groups and given to 450 subjects, were selected to obtain 300 observations per state. Subjects aged 18 to 75 years were recruited to be representative of the Italian general adult population for age, sex, and geographical distribution. To improve efficiency, face-to-face interviews were conducted by using the Computer Assisted Personal Interviewing approach. Several random effects regression models were tested to predict the full set of EQ-5D questionnaire health states. Model selection was based on logical consistency of the estimates, sign and magnitude of the regression coefficients, goodness of fit, and parsimony.Results The model that satisfied the criteria of logical consistency and was more efficient includes 10 main effect dummy variables for the EQ-5D questionnaire domain levels and the D1 interaction term, which accounts for the number of dimensions at levels 2 or 3 beyond the first. This model has an R(2) of 0.389 and a mean absolute error of 0.03, which are comparable to or better than those of models used in other countries. The utility estimates after state 11111 range from 0.92 (21111) to -0.38 (33333). Italian utility estimates are higher than those estimated in the United Kingdom and Spain and used so far to assess QALYs and conduct cost-utility evaluations in Italy.Conclusions A specific value set is now available to calculate QALYs for the conduction of health economic studies targeted at the Italian health care system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The study required between 128 and 172 participants to detect a two-tailed difference with statistical power 0.80 to 0.90.
“According to preventive inherent power and sample size, the study required between 128 (statistical power of 0.80; α = .05; 1 − β =0.80; t(126) = 1.97) and 172 participants (statistical power equal to 0.90, α = 0.05; 1 − β =0.90; t(179) = 1.97) to detect a two-tailed difference.”
From Promoting Acceptance and Adherence to Noninvasive Ventilation in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. (2022) · cites this paper as [45]
Citations
Cites
EQ-SD: a measure of health status from the EuroQol Group
Rabin, R., & Charro, F. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002087 · Cited by 5,613
(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544
Measuring Health: A Guide to Rating Scales and Questionnaires
McDowell, I., & Newell, C. (1987) · Cited by 4,207
Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets
van Hout, B., Janssen, M. F., Feng, Y.-S., Kohlmann, T., Busschbach, J., Golicki, D., Lloyd, A., Scalone, L., Kind, P., & Pickard, A. S. (2012) · Value in Health · doi:10.1016/j.jval.2012.02.008 · Cited by 2,153
Self-citationMcDowell, I. (2006) · doi:10.1093/acprof:oso/9780195165678.001.0001 · Cited by 2,121
Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., Swinburn, P., & Busschbach, J. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0322-4 · Cited by 1,582
Self-citationMeasuring Health: A Guide to Rating Scales and Questionnaires
Anderson, J. C. (1997) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199711000-00018 · Cited by 1,534
US Valuation of the EQ-5D Health States
Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005) · Medical Care · doi:10.1097/00005650-200503000-00003 · Cited by 1,282
The time trade-off method: Results from a general population study
Dolan, P., Gudex, C. M., Kind, P., & Williams, A. (1996) · Health Economics · doi:10.1002/(sici)1099-1050(199603)5:2 · Cited by 693
Szende, Á., Oppe, M., & Devlin, N. J. (2007) · Springer eBooks · doi:10.1007/1-4020-5511-0 · Cited by 678
The Dutch tariff: results and arguments for an effective design for national EQ‐5D valuation studies
Lamers, L. M., McDonnell, J., Stalmeier, P. F. M., Krabbe, P. F. M., & Busschbach, J. J. V. (2006) · Health Economics · doi:10.1002/hec.1124 · Cited by 625
Estimating an EQ‐5D population value set: the case of Japan
Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., Hamashima, C., Hisashige, A., & Tamura, M. (2002) · Health Economics · doi:10.1002/hec.673 · Cited by 564
Lee, Y.-K., Nam, H.-S., Chuang, L.-H., Kim, K.-Y., Yang, H.-K., Kwon, I.-S., Kind, P., Kweon, S.-S., & Kim, Y.-T. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00579.x · Cited by 474
Validating the EQ-5D with time trade off for the German population
Greiner, W., Claes, C., Busschbach, J. J. V., & von der Schulenburg, J. M. G. (2004) · The European Journal of Health Economics · doi:10.1007/s10198-004-0264-z · Cited by 376
Gringeri, A., Mantovani, L. G., Scalone, L., Mannucci, P. M., & the COCIS Study Group (2003) · Blood · doi:10.1182/blood-2003-03-0941 · Cited by 368
Self-citationBadia, X. C., Roset, M., Herdman, M., & Kind, P. (2001) · Medical Decision Making · doi:10.1177/0272989x0102100102 · Cited by 338
Generation of a Danish TTO value set for EQ-5D health states
Wittrup-Jensen, K. U., Lauridsen, J. T., Gudex, C. M., & Pedersen, K. M. (2009) · Scandinavian Journal of Public Health · doi:10.1177/1403494809105287 · Cited by 262
Time Trade-Off Derived EQ-5D Weights for Australia
Viney, R. C., Norman, R., King, M. T., Cronin, P., Street, D. J., Knox, S. A., & Ratcliffe, J. (2011) · Value in Health · doi:10.1016/j.jval.2011.04.009 · Cited by 260
Bansback, N. J., Tsuchiya, A., Brazier, J. E., & Anis, A. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031115 · Cited by 236
Valuations of EQ-5D Health States
Johnson, J. A., Luo, N., Shaw, J. W., Kind, P., & Coons, S. J. (2005) · Medical Care · doi:10.1097/00005650-200503000-00004 · Cited by 222
Valuing EQ-5D using Time Trade-Off in France
Chevalier, J., & de Pouvourville, G. (2011) · The European Journal of Health Economics · doi:10.1007/s10198-011-0351-x · Cited by 199
Population health metrics: crucial inputs to the development of evidence for health policy
Mathers, C. D., Murray, C. J. L., Ezzati, M., Gakidou, E. E., Salomon, J. A., & Stein, C. (2003) · Population Health Metrics · doi:10.1186/1478-7954-1-6 · Cited by 191
Scalone, L., Ciampichini, R., FAGIUOLI, S., Gardini, I., Fusco, F., Gaeta, L. M., Prete, A. D., Cesana, G., & Mantovani, L. G. (2012) · Quality of Life Research · doi:10.1007/s11136-012-0318-0 · Cited by 135
Self-citationArgentine Valuation of the EQ-5D Health States
Augustovski, F., Irazola, V. E., Velazquez, A. P., Gibbons, L., & Craig, B. M. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00468.x · Cited by 132
Estimating Population-Based Values for EQ-5D Health States in Thailand
Tongsiri, S., & Cairns, J. (2011) · Value in Health · doi:10.1016/j.jval.2011.06.005 · Cited by 132
The Members of the Italian Group for Pharmacoeconomic Studies, Capri, S., Ceci, A., Terranova, L., Merlo, D. F., & Mantovani, L. G. (2001) · Drug Information Journal · doi:10.1177/009286150103500122 · Cited by 125
Self-citationReal-life prospective study on asthma control in Italy: Cross-sectional phase results
Allegra, L., Cremonesi, G., Girbino, G., Ingrassia, E., Marsico, S. A., Nicolini, G., & Terzano, C. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.10.001 · Cited by 119
Golicki, D., Jakubczyk, M., Niewada, M., Wrona, W., & Busschbach, J. J. V. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00596.x · Cited by 110
Scalone, L., Mantovani, L. G., Krol, M., Rofail, D., Ravera, S., Bisconte, M. G., Borgna‐Pignatti, C., Borsellino, Z., Cianciulli, P., Gallisai, D., et al. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802160834 · Cited by 108
Self-citationTime trade-off user manual: props and self-completion methodsPreprint
Gudex, C. M. (1994) · RePEc: Research Papers in Economics · Cited by 104
Olivieri, I., Portu, S. D., Salvarani, C., Cauli, A., Lubrano, E., Spadaro, A., Cantini, F., Cutro, M. S., Mathieu, A., Matucci‐Cerinic, M., et al. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken320 · Cited by 90
Self-citationEstimating Quality Weights for EQ-5D Health States with the Time Trade-Off Method in South Korea
Jo, M., Yun, S., & Lee, S. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00348.x · Cited by 88
Social Valuation of EQ-5D Health States: The Chilean Case
Zárate, V., Kind, P., Valenzuela, P., Vignau, A., Olivares-Tirado, P., & Muñoz, A. F. (2011) · Value in Health · doi:10.1016/j.jval.2011.09.002 · Cited by 81
The Transformation of Utilities for Health States Worse Than Death
Lamers, L. M. (2007) · Medical Care · doi:10.1097/01.mlr.0000252166.76255.68 · Cited by 75
Statistical Versus Quantitative Significance in the Socioeconomic Evaluation of Medicines
OʼBrien, B. J., & Drummond, M. (1994) · PharmacoEconomics · doi:10.2165/00019053-199405050-00005 · Cited by 73
Estimating an EQ-5D Value Set for Malaysia Using Time Trade-Off and Visual Analogue Scale Methods
Yusof, F. A. M., Goh, A. Y. T., & Azmi, S. (2012) · Value in Health · doi:10.1016/j.jval.2011.11.024 · Cited by 69
Health outcomes in economic evaluation: who should value health?
Stamuli, E. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr001 · Cited by 68
Hispanic Valuation of the EQ-5D Health States: A Social Value Set for Latin Americans
Zárate, V., Kind, P., & Chuang, L. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00349.x · Cited by 63
Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets
Heijink, R., van Baal, P. H. M., Oppe, M., Koolman, X., & Westert, G. P. (2011) · Population Health Metrics · doi:10.1186/1478-7954-9-17 · Cited by 61
Faggioli, G., Scalone, L., Mantovani, L. G., Borghetti, F., & Stella, A. (2011) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2010.12.025 · Cited by 51
Self-citationComparison of Finnish and U.S.-based Visual Analog Scale Valuations of the EQ-5D Measure
Johnson, J. A., Ohinmaa, A. E., Murti, B., Sintonen, H., & Coons, S. J. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000304 · Cited by 48
An economic evaluation of an abdominal aortic aneurysm screening program in Italy
Giardina, S., Pane, B., Spinella, G., Cafueri, G., Corbo, M., Brasseur, P., Orengo, G., & Palombo, D. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.03.264 · Cited by 45
Craig, B. M., & Busschbach, J. J. V. (2009) · Population Health Metrics · doi:10.1186/1478-7954-7-3 · Cited by 40
Burden of Crohn’s disease: economics and quality of life aspects in Italy
Colombo, G., Benedini, V., Caporaso, N., Corazza, G. R., Rossi, Z., Fornaciari, G., Cottone, M., Frosini, G., Chiara, O., & Caruggi, M. (2012) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s31114 · Cited by 23
Proposta di linee guida per la valutazione economica degli interventi sanitari in Italia
Mapelli, V., & Aies, G. D. L. (2009) · doi:10.2165/00136178-200911020-00002 · Cited by 23
Proposta di linee guida per la valutazione economica degli interventi sanitari
Aguzzi, G., Baio, G., Capri, S., Cavazza, M., Cicchetti, A., Cislaghi, C., Colombo, G., Donatini, A., Fattore, G. L., Fiorini, M., et al. (2009) · Cited by 23
Health related quality of life assessment in patients with systemic sclerosis
Gualtierotti, R., Scalone, L., Ingegnoli, F., Cortesi, P. A., Lubatti, C., Zeni, S., & Meroni, P. L. (2011) · Reumatismo · doi:10.4081/reumatismo.2010.210 · Cited by 16
Self-citationRevisiting United States valuation of EQ-5D states
Craig, B. M., & Busschbach, J. J. V. (2011) · Journal of Health Economics · doi:10.1016/j.jhealeco.2011.07.009 · Cited by 14
Augestad, L. A., Rand, K., Kristiansen, I. S., & Stavem, K. (2012) · PharmacoEconomics · doi:10.2165/11595420-000000000-00000 · Cited by 12
Maino, F. (2005) · Cited by 10
UT1 VALUING EQ-5D USING TIME TRADE-OFF IN FRANCE
Chevalier, J., & de Pouvourville, G. (2009) · Value in Health · doi:10.1016/s1098-3015(10)74092-4 · Cited by 8
Flagged first, then by citations
2 of the 53 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Macran S, Kind P. Valuing EQ-5D health states using a modified MVH protocol: preliminary results. In: Badia X, Herdman M, Roset M, eds., Proceedings of the 16th Plenary Meeting of the EuroQol Group, pp. 205–40. Barcelona, Spain: Institut de SalutPublica de Catalunya, 2000.
Cited by
Sorted by citations
Self-Reported Population Health: An International Perspective based on EQ-5D
Szende, Á., Hita, J. M. C., & Janssen, B. (2013) · Springer eBooks · doi:10.1007/978-94-007-7596-1 · Cited by 811
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
Caraceni, P., Riggio, O., Angeli, P., Alessandria, C., Neri, S., Foschi, F. G., Levantesi, F., Airoldi, A., Boccia, S., Svegliati‐Baroni, G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30840-7 · Cited by 545
Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries
Janssen, M. F., Szende, Á., Hita, J. M. C., Ramos-Goñi, J. M., Vilagut, G., & König, H. ‐. (2018) · The European Journal of Health Economics · doi:10.1007/s10198-018-0955-5 · Cited by 346
The cost of severe haemophilia in Europe: the CHESS study
O’Hara, J., Hughes, D., Camp, C., Burke, T., Carroll, L., & Diego, D. G. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0660-y · Cited by 162
“Validated country-specific adult value sets obtained via the EuroQol website were used, with the exception of Italy, for which values were taken from literature [26].”
MethodEffects of early virtual reality-based rehabilitation in patients with total knee arthroplasty
Gianola, S., Stucovitz, E., Castellini, G., Mascali, M., Vanni, F., Tramacere, I., Banfi, G., & Tornese, D. (2020) · Medicine · doi:10.1097/md.0000000000019136 · Cited by 112
Montagnese, C., Porciello, G., Vitale, S., Palumbo, E., Crispo, A., Grimaldi, M., Calabrese, I., Pica, R., Prete, M., Falzone, L., et al. (2020) · Nutrients · doi:10.3390/nu13010136 · Cited by 125
“We have used the Italian health states value set [29] to obtain a unique health index score (EQ-5D-index), where the value of 1 represents the best health status and below 1 worse health status; in addition, EQ-VAS evaluates the participant’s self-reported health state on a scale from 0 (worse health status) to 100 be…”
MethodZucco, F., Ciampichini, R., Lavano, A., Costantini, A., Rose, M. D., Poli, P., Fortini, G., Demartini, L., Simone, E. D., Menardo, V., et al. (2015) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12292 · Cited by 93
Self-citationFinch, A. P., Meregaglia, M., Ciani, O., Roudijk, B., & Jommi, C. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.114519 · Cited by 91
Ricci, R. P., Vicentini, A., D’Onofrio, A., Sagone, A., Rovaris, G., Padeletti, L., Morichelli, L., Fusco, A., Vivo, S. D., Lombardi, L., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.09.008 · Cited by 79
Scalone, L., Cortesi, P. A., Ciampichini, R., Cesana, G., & Mantovani, L. G. (2022) · Epidemiology Biostatistics and Public Health · doi:10.2427/11457 · Cited by 79
“Italian Journal of Public Health, 2011; 8 (4): 331-341 [45] Scalone L, Cortesi PA, Ciampichini R, et al.”
BackgroundMethodInfluentialSelf-citationSalaffi, F., Carlo, M. D., Carotti, M., Farah, S., Ciapetti, A., & Gutiérrez, M. (2019) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v89i4.7298 · Cited by 81
Cervigni, M., Sommariva, M., Tenaglia, R. L., Porru, D., Ostardo, E., Giammò, A., Trevisan, S., Frangione, V., Ciani, O., Tarricone, R., et al. (2016) · Neurourology and Urodynamics · doi:10.1002/nau.23091 · Cited by 70
Cultural Values: Can They Explain Differences in Health Utilities between Countries?
Roudijk, B., Donders, A. R. T., Stalmeier, P. F. M., Luo, N., Viney, R. C., Andrade, M. V., Gudex, C. M., de Pouvourville, G., Greiner, W., Scalone, L., et al. (2019) · Medical Decision Making · doi:10.1177/0272989x19841587 · Cited by 69
Self-citationPorciello, G., Montagnese, C., Crispo, A., Grimaldi, M., Libra, M., Vitale, S., Palumbo, E., Pica, R., Calabrese, I., Cubisino, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239803 · Cited by 73
Maresca, G., Maggio, M. G., Latella, D., Cannavò, A., De Cola, M. C., Portaro, S., Stagnitti, M. C., Silvestri, G., Torrisi, M., Bramanti, A., et al. (2019) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2019.104303 · Cited by 67
Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk
Cesaro, A., Gragnano, F., Fimiani, F., Moscarella, E., Diana, V., Pariggiano, I., Concilio, C., Natale, F., Limongelli, G., Bossone, E., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319839179 · Cited by 66
Ciani, O., Arendsen, E. H., Romancik, M., Lunik, R., Costantini, E., Biase, M. D., Morgia, G., Fragalà, E., Tomaskin, R., Bernat, M., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009669 · Cited by 66
New insights into the burden and costs of multiple sclerosis in Europe: Results for Italy
Battaglia, M. A., Kobelt, G., Ponzio, M., Berg, J., Capsa, D., Dalén, J., & Platform, T. E. M. S. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517708176 · Cited by 60
“Health-care costs 20,132 (15,256) 23,611 (38,354) 15,670 (39,762) Inpatient care 769 (8435) 5133 (36,356) 7091 (36,839) Day admission 805 (2954) 1924 (4967) 1211 (3759) Consultations 315 (567) 959 (1645) 1137 (1615) Tests 671 (771) 749 (819) 268 (553) Medication 394 (558) 704 (830) 999 (1106) DMTs 17,177 (11,340) 14,1…”
Goudarzi, R., Zeraati, H., Sari, A. A., Rashidian, A., & Mohammad, K. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.21584 · Cited by 56
“The EQ-5D defines the level of “mobility” (MO), “selfcare” (SC), “usual activities” (UA), “pain/discomfort” (PD), and “anxiety/depression” (AD) (14).”
MethodGeneral population normative data for the EQ-5D-3L in the five largest European economies
Janssen, M. F., Pickard, A. S., & Shaw, J. W. (2021) · The European Journal of Health Economics · doi:10.1007/s10198-021-01326-9 · Cited by 55
Zangrillo, A., Belletti, A., Palumbo, D., Calvi, M. R., Guzzo, F., Fominskiy, E. V., Ortalda, A., Nardelli, P., Ripa, M., Redaelli, M. B., et al. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.11.032 · Cited by 57
Broekhuizen, K., Simmons, D. S., Devlieger, R., Assche, A. V., Jans, G., Galjaard, S., Corcoy, R., Adelantado, J. M., Dunne, F., Desoyé, G., et al. (2018) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-018-0643-y · Cited by 60
Goudarzi, R., Sari, A. A., Zeraati, H., Rashidian, A., Mohammad, K., & Amini, S. (2019) · Value in Health Regional Issues · doi:10.1016/j.vhri.2019.01.007 · Cited by 54
Monti, G., Leggieri, C., Fominskiy, E. V., Scandroglio, A. M., Colombo, S., Tozzi, M., Moizo, E., Mucci, M., Crivellari, M., Pieri, M., et al. (2021) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13812 · Cited by 49
The societal burden of chronic liver diseases: results from the COME study
Scalone, L., FAGIUOLI, S., Ciampichini, R., Gardini, I., Bruno, R., PASULO, L., Lucà, M. G., Fusco, F., Gaeta, L. M., Prete, A. D., et al. (2015) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2014-000025 · Cited by 47
“can depend on a number of reasons, for example, the different methods and different study samples adopted in the different studies, and the different levels of the social tariffs used to obtain utilities: as regards the Italian social tariffs used to obtain utilities in the present study, we found them systematically…”
ResultSelf-citationYang, F. B., Wong, C. K. H., Luo, N., Piercy, J., Moon, R., & Jackson, J. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-019-01088-5 · Cited by 45
Ciani, O., Pascarelli, N. A., Giannitti, C., Galeazzi, M., Meregaglia, M., Fattore, G., & Fioravanti, A. (2016) · Arthritis Care & Research · doi:10.1002/acr.23116 · Cited by 44
Health related quality of life in chronic liver diseases
Cortesi, P. A., Conti, S., Scalone, L., Jaffe, A., Ciaccio, A., Okolicsanyi, S., Rota, M., Fabris, L., Colledan, M., FAGIUOLI, S., et al. (2020) · Liver International · doi:10.1111/liv.14647 · Cited by 41
Self-citationEQ-5D-5L Population Norms for Italy
Meregaglia, M., Malandrini, F. B., Finch, A. P., Ciani, O., & Jommi, C. (2022) · Applied Health Economics and Health Policy · doi:10.1007/s40258-022-00772-7 · Cited by 41
“1 years), since participants were recruited up to a maximum of 75 years [51].”
BackgroundMethodChevreul, K., Gandré, C., Brigham, K. B., López‐Bastida, J., Linertová, R., Oliva, J., Serrano-Aguilar, P. G., de la Paz, M. P., Taruscio, D., Schieppati, A., et al. (2016) · The European Journal of Health Economics · doi:10.1007/s10198-016-0784-3 · Cited by 43
“In Italy, mean VAS score for adult FXS patients was lower than that measured in a sample representative of the Italian general population [47] and lower than the mean value for patients affected by HIV [48], similar to what was observed in Spain [49].”
ResultHow to measure chronic pain: New concepts
Salaffi, F., Sarzi‐Puttini, P., & Atzeni, F. (2015) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2015.04.023 · Cited by 43
Feasibility and Efficacy of the Pulmonary Rehabilitation Program in a Rehabilitation Center
Pancera, S., Galeri, S., Porta, R., Pietta, I., Bianchi, L. N. C., Carrozza, M. C., & Villafañe, J. H. (2020) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000529 · Cited by 39
Exclusion Criteria in National Health State Valuation Studies
Engel, L., Bansback, N. J., Bryan, S., Doyle‐Waters, M. M., & Whitehurst, D. G. T. (2015) · Medical Decision Making · doi:10.1177/0272989x15595365 · Cited by 36
Gamper, E., Cottone, F., Sommer, K., Norman, R., King, M. T., Breccia, M., Caocci, G., Patriarca, A., Palumbo, G. A., Stauder, R., et al. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.03.015 · Cited by 35
Scalone, L., Zucco, F., Lavano, A., Costantini, A., Rose, M. D., Poli, P., Fortini, G., Demartini, L., Simone, E. D., Menardo, V., et al. (2018) · Health and Quality of Life Outcomes · doi:10.1186/s12955-018-0887-x · Cited by 34
“Considering the specificity of the FBSS with refractoriness to conventional medical management, which requires high level of expertise necessary for the adoption of SCS, we found 9 specialized centers (6 pain units and 3 neurosurgery wards) able to participate across Italy, all having at least five years of experience…”
MethodInfluentialSelf-citationCarlo, M. D., Lato, V., Carotti, M., & Salaffi, F. (2016) · Health and Quality of Life Outcomes · doi:10.1186/s12955-016-0463-1 · Cited by 33
“38 [22].”
Work Difficulties in People with Multiple Sclerosis
Ponzio, M., Podda, J., Pignattelli, E., Verri, A. P., Persechino, B., Vitturi, B. K., Bandiera, P., Manacorda, T., Inglese, M., Durando, P., et al. (2023) · Journal of Occupational Rehabilitation · doi:10.1007/s10926-023-10149-9 · Cited by 33
“Utilities were estimated using the tariff developed by Scalone based on individuals from the Italian general population [37].”
MethodO’Hara, S., Castro, F. A., Black, J. M., Chaplin, S., Ruiz, L., Hampton, R., Sima, C. S., & O’Hara, J. (2020) · Haemophilia · doi:10.1111/hae.14171 · Cited by 31
Assessing the Impact of EQ-5D Country-specific Value Sets on Cost-utility Outcomes
van Dongen, J. M., Ben, Â. J., Finch, A. P., Rossenaar, M. M. M., Biesheuvel-Leliefeld, K. E. M., Apeldoorn, A. T., Ostelo, R., van Tulder, M. W., van Marwijk, H., & Bosmans, J. E. (2020) · Medical Care · doi:10.1097/mlr.0000000000001417 · Cited by 29
Eriksson, J., Kobelt, G., Gannedahl, M., & Berg, J. (2018) · Value in Health · doi:10.1016/j.jval.2018.08.002 · Cited by 29
Matthews, S., María, A., Passamonti, M., Ristori, G., Loiacono, I., Puggina, A., & Curran, D. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz007 · Cited by 28
“011 per month) using the recently published Italian time-trade-off values [13].”
MethodThe Effect of Neuropathic Pain Symptoms on Remission in Patients with Early Rheumatoid Arthritis
Salaffi, F., Carlo, M. D., Carotti, M., & Sarzi‐Puttini, P. (2018) · Current Rheumatology Reviews · doi:10.2174/1573397114666180806142814 · Cited by 27
Rossettini, G., Palese, A., Geri, T., Mirandola, M., Tortella, F., & Testa, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00478 · Cited by 30
“Furthermore, the patients’ health status as measured with the EQI was similar to that of the general population (48).”
MethodResultVolpato, E., Banfi, P., & Pagnini, F. (2022) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001053 · Cited by 24
Ludwig, C., Luthy, C., Allaz, A., Herrmann, F. R., & Cedraschi, C. (2017) · European Spine Journal · doi:10.1007/s00586-017-5427-6 · Cited by 27
Mennini, F. S., Meucci, F., Pesarini, G., Vandoni, P., Lettino, M., Sarmah, A., Shore, J., Green, M., & Giardina, S. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.03.034 · Cited by 25
Mozzi, A., Meregaglia, M., Lazzaro, C. R., Tornatore, V., Belfiglio, M., & Fattore, G. (2016) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s98226 · Cited by 24
“Results reveal remarkable differences among the three national tariff sets (especially when severe health states occur) suggesting the need for country-specific preference weights when evaluating health-related utilities.(4,14,19,20) This also leads to the question of which preference weights should be used in cost-ef…”
BackgroundHealth economic models in hemophilia A and utility assumptions from a clinician's perspective
Valente, M., Cortesi, P. A., Lassandro, G., Mathew, P., Pocoski, J., Molinari, A. C., Mantovani, L. G., & Giordano, P. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25543 · Cited by 23
Self-citationHumeral shaft non-union in the elderly: Results with cortical graft plus stem cells
Toro, G., Lepore, F., Calabrò, G., Toro, G., Rossini, M., Vasso, M., & Panni, A. S. (2019) · Injury · doi:10.1016/j.injury.2019.01.050 · Cited by 23
Unmet needs influence health-related quality of life in people with multiple sclerosis
Ponzio, M., Tacchino, A., Vaccaro, C. M., Traversa, S., Brichetto, G., Battaglia, M. A., & Uccelli, M. M. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101877 · Cited by 22
Boye, K. S., Matza, L. S., Stewart, K. D., Jordan, J. B., Biricolti, G., Santo, S. D., Perez‐Nieves, M., Federici, M. O., Gentilella, R., Losi, S., et al. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1609482 · Cited by 22
Leo, S., Arnoldi, E., Repetto, L., Coccorullo, Z., Cinieri, S., Fedele, P., Cazzaniga, M. E., Lorusso, V., Latorre, A. C., Campanella, G. A., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0676 · Cited by 21
Ciaccio, A., Cortesi, P. A., Bellelli, G., Rota, M., Conti, S., Okolicsanyi, S., Rota, M., Cesana, G., Mantovani, L. G., Annoni, G., et al. (2016) · Liver International · doi:10.1111/liv.13339 · Cited by 20
Self-citationGorini, A., Giuliani, M., L'Acqua, C., Barbieri, S., Sisillo, E., Veglia, F., & Tremoli, E. (2022) · Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000792 · Cited by 22
Cortesi, P. A., Ciaccio, A., Rota, M., Lim, J. K., Salvia, S. D., Okolicsanyi, S., Vinci, M. R., Belli, L. S., Mantovani, L. G., & Strazzabosco, M. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12278 · Cited by 19
“To assess the utility weights, we applied the recently estimated EQ-5D-3L Italian algorithm [21].”
MethodSelf-citationSalaffi, F., Ciapetti, A., Carotti, M., Gasparini, S., Citera, G., & Gutiérrez, M. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0129-9 · Cited by 19
Morucci, G., Ryskalin, L., Pratesi, S., Branca, J. J. V., Modesti, A., Modesti, P. A., Gulisano, M., & Gesi, M. (2022) · Medicina · doi:10.3390/medicina58101341 · Cited by 24
“The results of the EuroQoL 5-D 3-L health questionnaire may be converted from a descriptive system into a single index value [33].”
BackgroundMaghnie, M., Orso, M., Polistena, B., Cappa, M., Pozzobon, G. C., D’Angela, D., Patti, G., Spandonaro, F., Granato, S., Virgilio, R. D., et al. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02106-3 · Cited by 19
“The algorithm proposed by Scalone et al. [8] describes the translation of the EQ-5D-3L results in quality-adjusted life years (QALYs) specific to the Italian population.”
MethodMatza, L. S., Boye, K. S., Jordan, J. B., Norrbacka, K., Gentilella, R., Tiebout, A. R., Browne, C., Federici, M. O., Biricolti, G., & Stewart, K. D. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s159620 · Cited by 19
“The EQ-5D-3L index score was computed using published Italian tariffs.(33)”
Ralli, M., Quaranta, N. A. A., Canale, A., Röösli, C., Milella, C., Robertis, V. D., de Soccio, G., Greco, A., Ralli, G., Albera, R., et al. (2019) · Otology & Neurotology · doi:10.1097/mao.0000000000002131 · Cited by 18
Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
Codecasa, L. R., Toumi, M., D’Ausilio, A., Aiello, A., Damele, F., Termini, R., Uglietti, A., Hettle, R., Graziano, G., & Lorenzo, S. D. (2017) · Journal of Market Access & Health Policy · doi:10.1080/20016689.2017.1283105 · Cited by 18
Palliative Surgery or Metallic Stent Positioning for Advanced Gastric Cancer: Differences in QOL
Fiori, E., Crocetti, D., Sapienza, P., Cirocchi, R., Sterpetti, A. V., Miccini, M., Accordino, M., Costi, S., Lapolla, P., Mingoli, A., et al. (2021) · Medicina · doi:10.3390/medicina57050428 · Cited by 18
“The QoL was studied with the EQ-5D-5L™ questionnaire (©EuroQol Group, Rotterdam, The Netherlands) [12] involving the following areas of investigations (mobility, self-care activities, usual activities, pain/discomfort, and anxiety/depression) with each dimension graded into five levels (i.e., no problem/slight problem…”
MethodInfluentialFeasibility, acceptability and construct validity of EQ-5D in systemic sclerosis
Gualtierotti, R., Ingegnoli, F., Scalone, L., Cortesi, P. A., Bruschi, E., Gerosa, M., & Meroni, P. L. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14394 · Cited by 17
Self-citationSurvey about the Quality of Life of Italian Patients with Fabry Disease
Polistena, B., Rigante, D., Sicignano, L. L., Verrecchia, E., Manna, R., D’Angela, D., & Spandonaro, F. (2021) · Diseases · doi:10.3390/diseases9040072 · Cited by 16
“In the last few years, the EQ-5D has been largely used in Italy for evaluating individual health states in different conditions [13].”
BackgroundMethodFiori, E., Lamazza, A., Sterpetti, A. V., Crocetti, D., Felice, F. D., Muzio, M. D., Mingoli, A., Sapienza, P., & Toma, G. D. (2019) · In Vivo · doi:10.21873/invivo.11705 · Cited by 15
Kodra, Y., Cavazza, M., Santis, M. D., Guala, A., Liverani, M. E., Armeni, P., Masini, M., & Taruscio, D. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17165951 · Cited by 15
“In Italy, mean VAS score for Cri du Chat patients was lower than that measured in a sample representative of the Italian general population [28].”
BackgroundHunter, R. M., Wallace, P., Struzzo, P., Vedova, R. D., Scafuri, F., Tersar, C., Lygidakis, C., McGregor, R., Scafato, E., & Freemantle, N. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014577 · Cited by 14
Александрова, Е. А., Khabibullina, A. R., Aistov, A. V., Габдулхаевна, Г. Ф., Gerry, C., Давитадзе, А. П., Zazdravnykh, E. A., Kislitsyn, D., Kuznetsova, M. Y., Kupera, A. V., et al. (2020) · Сибирский научный медицинский журнал · doi:10.15372/ssmj20200314 · Cited by 15
Valuation of the EQ-5D-3L in Jordan
Rabayah, A. A., Roudijk, B., Purba, F. D., Rencz, F., Jaddoua, S. M., & Siebert, U. (2024) · The European Journal of Health Economics · doi:10.1007/s10198-024-01712-z · Cited by 14
“As in many previously published valuation studies [18, 45–47], our study showed that severe problems in usual activities had the smallest impact on health-related quality of life with a utility decrement of (− 0.135).”
Influential“Back to the future”: Influence of beliefs regarding the future on TTO answers
van Nooten, F. E., van Exel, J. N. A., Eriksson, D., & Brouwer, W. B. F. (2016) · Health and Quality of Life Outcomes · doi:10.1186/s12955-015-0402-6 · Cited by 12
“Societal preferences obtained in the general public typically underlie these values [2, 3].”
Geri, T., Gizzi, L., Marco, A. D., & Testa, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-52561-3 · Cited by 12
Estimating an EQ-5D-3L Value Set for Romania Using Time Trade-Off
Paveliu, M. S., Olariu, E., Caplescu, R. D., Oluboyede, Y., Niculescu-Aron, I. G., Ernu, S., & Vale, L. D. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18147415 · Cited by 12
“To measure health outcomes, country-specific index values (utilities) have been developed in many other countries: in Belgium [10], Denmark [11], France [12], Germany [13,14], Greece [15], Holland [16], Italy [17], Poland [18,19], Portugal [20], Spain [21], Slovenia [22], Sweden [23], and the United Kingdom [24,25].”
BackgroundSalaffi, F., Carlo, M. D., Carotti, M., & Farah, S. (2018) · Pain Research and Management · doi:10.1155/2018/3496846 · Cited by 14
Impact of multiple sclerosis comorbidities on quality of life and job activity
Mallucci, G., Monti, M. C., Ponzio, M., Borrelli, P., Montomoli, C., & Bergamaschi, R. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241260550 · Cited by 11
eq5d: Methods for Analysing 'EQ-5D' Data and Calculating 'EQ-5D' Index Scores
Morton, F. J., & Nijjar, J. S. (2019) · doi:10.32614/cran.package.eq5d · Cited by 11
Parel, I., Candoli, V., Filippi, M. V., Padolino, A., Merolla, G., Sanniti, S., Galassi, R., Paladini, P., & Cutti, A. G. (2022) · JMIR Research Protocols · doi:10.2196/35757 · Cited by 11
Procopio, G., Chiurì, V. E., Giordano, M., Mantini, G., Maisano, R., Bordonaro, R., Calvani, N., Facchini, G., Placido, S. D., Airoldi, M., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920968725 · Cited by 10
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
Rognoni, C., Falivena, C., Costa, F., & Armeni, P. (2023) · PharmacoEconomics · doi:10.1007/s40273-022-01220-z · Cited by 10
“For the estimation of the utility coefficients for the health states of the model, the Italian algorithm has been applied [40] to EuroQol 5D-5L data collected during the TRANSFORM-2 study [14].”
MethodGuberti, M., Botti, S., Fusco, A., Caffarri, C., Cavuto, S., Savoldi, L., Serra, N., Merli, F., Piredda, M., & Marinis, M. G. D. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07073-8 · Cited by 9
“Three different analyses of the EQ-5D-3L data were done at each time point: the cohort’s health profile description was reported as frequencies and percentages of the 3 levels of perceived problems (no, mild, severe) on mobility, self-care, usual activity, pain/ discomfort, anxiety/depression; central tendency measure…”
MethodCost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment
Cortesi, P. A., D’Angiolella, L. S., Vellucci, R., Allegri, M., Casale, G., Favaretti, C., Kheiraoui, F., Cesana, G., & Mantovani, L. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179523 · Cited by 9
Self-citationŁaszewska, A., Sajjad, A., Busschbach, J. J. V., Simon, J., & Roijen, L. H. (2022) · PharmacoEconomics · doi:10.1007/s40273-022-01194-y · Cited by 8
“Southern Portugal, Malta, Spain, Italy, Cyprus, Greece Italy [77], Portugal [16], Spain [36] Italy [78], Portugal [79], Spain [80]”
BackgroundBoye, K. S., Lebrec, J., Dib, A., Heitmann, E., Federici, M. O., Yu, M., Sapin, H., Barrett, A., Guerci, B., Giorgino, F., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15145 · Cited by 8
“21 – 23 The Impact of Weight on Self-Perceptions questionnaire (IW-SP) is designed to assess how self-perceptions of individuals with T2D or obesity are affected by their body weight.”
BackgroundOremus, M., Sharafoddini, A., Morgano, G. P., Jin, X., & Xie, F. (2018) · JMIR Formative Research · doi:10.2196/formative.8202 · Cited by 8
Panico, G., Vacca, L., Campagna, G., Lombisani, A., Caramazza, D., Caporale, N., Scambia, G., & Ercoli, A. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.03.035 · Cited by 8
Negrini, F., Lucia, F. D., Négrini, S., Tornese, D., Facchini, F., Vecchio, M. M., & de Girolamo, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.718060 · Cited by 8
“Starting from the raw values of EQ-5D, we calculated the utility value needed to estimate quality-adjusted life-years (QALYs), using the country-specific correction proposed by Scalone et al. (Scalone et al., 2013).”
MethodIdiopathic normal pressure hydrocephalus: postoperative patient perspective and quality of life
Belotti, F., Pertichetti, M., Muratori, A., Migliorati, K., Panciani, P. P., Draghi, R., Godano, U., Borghesi, I., & Fontanella, M. M. (2022) · Acta Neurochirurgica · doi:10.1007/s00701-022-05275-x · Cited by 8
Ramos-Gonñi, J. M., Rivero‐Arias, O., & Dakin, H. (2013) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x1301300303 · Cited by 8
“However, the modeling exercise conducted in the United States (Szende, Oppe, and Devlin 2007) and in Italy (Scalone et al. 2013) followed different strategies.”
Ponzio, M., Santoni, L., Molina, M., Tavazzi, E., & Bergamaschi, R. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12729-y · Cited by 7
“The EQ-5D results were translated into utilities based on the Italian tariff established by Scalone et al. [20], giving a utility value between 0 (death) and 1 (full health) [15], as negative values were put to 0 in this analysis.”
Maffulli, N., Gougoulias, N. E., Maffulli, G. D., Oliva, F., & Migliorini, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-10730-x · Cited by 7
In search of a ‘pan-European value set’; application for EQ-5D-3L
Sajjad, A., Versteegh, M., Santi, I., Busschbach, J. J. V., Simon, J., & Roijen, L. H. (2023) · BMC Medical Research Methodology · doi:10.1186/s12874-022-01830-3 · Cited by 7
Rumi, F., Basile, M., Cicchetti, A., Alvarez, F. P., Azzi, M. V., & Muzii, B. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1200116 · Cited by 7
“In the QALY calculation, the model population expected life years accrued were adjusted by Italian population age-specific utility values (24).”
BackgroundMethodPilz, M. J., Seyringer, S., Al-Naesan, I., King, M. T., Bottomley, A., Norman, R., Schlosser, L., Hell, T., Gamper, E., & the EORTC Quality of Life Group (2024) · PharmacoEconomics - Open · doi:10.1007/s41669-024-00484-9 · Cited by 7
“Here, we used the utility decrements of Australia [46, 54], Canada [47, 55], Italy [43, 56], the Netherlands [44, 57], Poland [43, 58], and the United Kingdom [49, 59].”
MethodSteg, P. G., Bhatt, D. L., James, S. K., Darlington, O. T., Hoskin, L., Simon, T., Fox, K. M., Leiter, L. A., Mehta, S. R., Harrington, R. A., et al. (2022) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvac032 · Cited by 7
“31 Utility estimates were adjusted for patient characteristics, study follow-up, the incidence of MI, stroke, TIMI bleeding events, and adverse events.”
Ghetti, G., D’Avella, M. C., & Pradelli, L. (2021) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s295605 · Cited by 6
Cementless Ceramic-on-Ceramic Total Hip Replacement in Children and Adolescents
Trisolino, G., Stallone, S., Castagnini, F., Bordini, B., Cosentino, M., Lucchini, S., Zarantonello, P., Ferrari, D., Dallari, D., & Traina, F. (2021) · Children · doi:10.3390/children8100858 · Cited by 6
“Patients were contacted by mail or by phone and were asked to fulfill the Italian version of the Hip disability and Osteoarthritis Outcome Score (HOOS) [19], the University of California at Los Angeles (UCLA) Activity Score [20] and EQ-5D [21] questionnaire.”
MethodUlivi, M., Orlandini, L. C., Meroni, V., Viganò, M., D’Errico, M., Perrotta, R., Nannini, A., Peretti, G. M., & Mangiavini, L. (2022) · Healthcare · doi:10.3390/healthcare10050769 · Cited by 6
“EQ-5D is a questionnaire designed to evaluate the quality of life aiming at assessing the general health status and is usually applied to a vast range of diseases/health conditions [22,23].”
BackgroundMatza, L. S., Osumili, B., Stewart, K. D., Perez‐Nieves, M., Jordan, J. B., Biricolti, G., Romoli, E., Losi, S., Santo, S. D., Spaepen, E., et al. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00718-8 · Cited by 6
Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off
Wang, X., Zhuo, L., Ma, Y., Cai, T., Must, A., Xu, L., & Zhuo, L. (2020) · BMC Medical Research Methodology · doi:10.1186/s12874-020-01008-9 · Cited by 6
Procopio, G., Chiurì, V. E., Giordano, M., Alitto, A. R., Maisano, R., Bordonaro, R., Cinieri, S., Rossetti, S., Placido, S. D., Airoldi, M., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100431 · Cited by 6
“A unique health index score is calculated through an algorithm that attaches coefficients to each of the levels in each dimension; we used the Italian model to estimate the EQ-5D-3L index score.(20) In addition, the EQ-5D-3L questionnaire includes a visual analog scale (EQ VAS) which measures the patient’s overall hea…”
MethodBonifacio, M., Maheshwari, V. K., Tran, D., AGOSTONI, G., Filioussi, K., & Viana, R. (2021) · PharmacoEconomics - Open · doi:10.1007/s41669-021-00286-3 · Cited by 6
Metadata
- Authors
- Scalone, L., Cortesi, P. A., Ciampichini, R., Belisari, A., D’Angiolella, L. S., Cesana, G., & Mantovani, L. G.
- Affiliations
- University of Milano-Bicocca (IT)
- University of Naples Federico II (IT)
- Corresponding author
- Scalone, Luciana
- ORCID
- Venue
- Value in Health
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 16
- Issue
- 5
- Pages
- 814-822
- ISSN
- 1098-3015 (ISSN-L)
- OpenAlex
- W2051424809
- Cited by
- 145
- References
- 53
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 8 · 2023: 15 · 2022: 14 · 2021: 19 · 2020: 15 · 2019: 16 · 2018: 10 · 2017: 10 · 2016: 13 · 2015: 7 · 2014: 3 · 2013: 2
- FWCI
- 19.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Value in Health (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Funders
- Università degli Studi di Milano
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
- Social Sciences › Sociology and Political Science › Delphi Technique in Research
- Keywords
- EQ-5D, health utility, time trade-off, quality-adjusted life years, health state valuation
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Attitude to Health, Cost-Benefit Analysis, Female, Health Status, Humans, Italy, Male, Middle Aged, Psychometrics, Quality of Life, Sex Factors, Socioeconomic Factors, Time Factors, Quality-Adjusted Life Years, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review